ATA807178A - Verfahren zur herstellung von neuen cephalosporan-saeurederivaten - Google Patents
Verfahren zur herstellung von neuen cephalosporan-saeurederivatenInfo
- Publication number
- ATA807178A ATA807178A AT0807178A AT807178A ATA807178A AT A807178 A ATA807178 A AT A807178A AT 0807178 A AT0807178 A AT 0807178A AT 807178 A AT807178 A AT 807178A AT A807178 A ATA807178 A AT A807178A
- Authority
- AT
- Austria
- Prior art keywords
- cephalosporane
- new
- production
- acid derivatives
- derivatives
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT491181A AT376663B (de) | 1977-11-14 | 1981-11-13 | Verfahren zur herstellung von neuen pyridinund phyrimidinverbindungen und deren salzen |
AT490881A AT371822B (de) | 1977-11-14 | 1981-11-13 | Verfahren zur herstellung von neuen cephalosporansaeurederivaten |
AT491081A ATA491081A (de) | 1977-11-14 | 1981-11-13 | Verfahren zur herstellung von neuen pyridin und pyrimidinverbindungen und deren salzen |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4735277 | 1977-11-14 | ||
GB1681078 | 1978-04-27 | ||
GB7835436 | 1978-09-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA807178A true ATA807178A (de) | 1982-04-15 |
AT369005B AT369005B (de) | 1982-11-25 |
Family
ID=27257420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0807178A AT369005B (de) | 1977-11-14 | 1978-11-10 | Verfahren zur herstellung von neuen cephalosporan-saeurederivaten |
Country Status (15)
Country | Link |
---|---|
US (3) | US4267176A (de) |
JP (1) | JPS5492987A (de) |
AT (1) | AT369005B (de) |
AU (1) | AU523346B2 (de) |
CA (1) | CA1120923A (de) |
CH (1) | CH645904A5 (de) |
DE (1) | DE2848912A1 (de) |
DK (1) | DK502078A (de) |
ES (5) | ES475035A1 (de) |
FR (2) | FR2411839B1 (de) |
GB (1) | GB2010840B (de) |
HU (2) | HU183008B (de) |
IT (1) | IT1192287B (de) |
NL (1) | NL7811220A (de) |
SE (2) | SE7811637L (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1192287B (it) * | 1977-11-14 | 1988-03-31 | Fujisawa Pharmaceutical Co | Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione |
DE2818263A1 (de) * | 1978-04-26 | 1979-11-08 | Bayer Ag | Beta-lactamantibiotika |
US4409214A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical, Co., Ltd. | 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof |
JPS5716886A (en) * | 1980-07-04 | 1982-01-28 | Fujisawa Pharmaceut Co Ltd | Azetidinone bearing oxo group or its salt or hydrate and their preparation |
DE3175156D1 (en) * | 1980-08-29 | 1986-09-25 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
US4577014A (en) * | 1981-09-08 | 1986-03-18 | Eli Lilly And Company | Thieno and furopyridinium-substituted cephalosporins |
US4402955A (en) * | 1981-10-02 | 1983-09-06 | Eli Lilly And Company | Dioximino cephalosporin antibiotics |
US4379787A (en) * | 1981-10-02 | 1983-04-12 | Eli Lilly And Company | Oximino-substituted cephalosporin compounds |
US4450270A (en) * | 1981-10-02 | 1984-05-22 | Eli Lilly And Company | Dioximino cephalosporin antibiotics |
US4501739A (en) * | 1982-01-19 | 1985-02-26 | Eli Lilly And Company | Thieno and furopyridinium-substituted cephalosporins |
US4683227A (en) * | 1985-07-09 | 1987-07-28 | Eli Lilly And Company | Antibiotic derivatives of 7β-[2-(thiazol-4-yl)acetamide]-3-chloro-3-cephem-4-carboxylic acids and compositions and method of use thereof |
CN102988362B (zh) * | 2005-12-07 | 2014-11-05 | 巴斯利尔药物股份公司 | 单环-内酰胺类抗生素与β-内酰胺酶抑制剂的有效的联合应用 |
EA028342B1 (ru) | 2011-09-09 | 2017-11-30 | Мерк Шарп И Доум Корп. | Способы лечения пневмонии |
US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
NZ700372A (en) | 2013-03-15 | 2016-01-29 | Merck Sharp & Dohme | Ceftolozane antibiotic compositions |
US20140274997A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Cephalosporin pharmaceutical compositions |
EP3043797B1 (de) | 2013-09-09 | 2020-04-08 | Merck Sharp & Dohme Corp. | Behandlung von infektionen mit ceftolozan/tazobactam bei personen mit beeinträchtigter nierenfunktion |
US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3459746A (en) * | 1965-10-04 | 1969-08-05 | Lilly Co Eli | 7 - heteromonocyclic-substituted acylamido derivatives of desacetyl cephalosporanic acid |
GB1195203A (en) * | 1966-06-24 | 1970-06-17 | Glaxo Lab Ltd | Cephalosporins |
CH527215A (de) * | 1967-04-15 | 1972-08-31 | Fujisawa Pharmaceutical Co | Verfahren zur Herstellung von 3,7-disubstituierten Cephalosporinderivaten |
CH522677A (de) * | 1969-10-10 | 1972-06-30 | Ciba Geigy Ag | Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure |
FR2068419A1 (en) * | 1969-10-27 | 1971-08-27 | Fujisawa Pharmaceutical Co | Antibacterial cephalosporin compsns |
IL39094A (en) * | 1971-04-21 | 1976-05-31 | Ciba Geigy Ag | 7-(aminopyridiniumacetyl)-3-heterocyclylthiomethyl-cephalosporanic acid derivatives,their manufacture and pharmaceutical compositions containing them |
US4017515A (en) * | 1971-05-14 | 1977-04-12 | Glaxo Laboratories Limited | α-(Etherified oximino) carboxylic acids and acid chlorides |
GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
US4033950A (en) * | 1971-05-14 | 1977-07-05 | Glaxo Laboratories Limited | 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof |
US3966717A (en) * | 1971-05-14 | 1976-06-29 | Glaxo Laboratories Limited | 7-β-Acylamido-3-carbamoyloxymethylceph-3-em-4-carboxylic acids and salts thereof |
DE2222791A1 (de) * | 1971-05-19 | 1972-12-07 | Ciba Geigy Ag | Neue Pyridinessigsaeurederivate und Verfahren zu ihrer Herstellung |
BE790287A (fr) * | 1971-10-28 | 1973-04-19 | Delalande Sa | Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique |
BE793724A (fr) * | 1972-01-12 | 1973-07-05 | Smith Kline French Lab | Procede de preparation de cephalosphorines non substituees en position 3, nouvelles cephalosporines obtenues et leur utilisation |
AR208171A1 (es) * | 1972-09-29 | 1976-12-09 | Ciba Geigy Ag | Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico |
GB1390141A (en) * | 1973-01-08 | 1975-04-09 | Ici Ltd | Pyrimidine derivatives and processes for their production |
JPS5932472B2 (ja) * | 1973-03-15 | 1984-08-09 | 藤沢薬品工業株式会社 | 2−アルキル−7−アシルアミノ−2(または3)−セフエム−4−カルボン酸類の製造法 |
JPS4970990A (de) * | 1973-09-29 | 1974-07-09 | ||
US3968109A (en) * | 1973-11-23 | 1976-07-06 | E. R. Squibb & Sons, Inc. | Production of 2-(thio substituted)cephalosporin sulfoxides and 2-(thio substituted)cephalosporins |
FR2262965A1 (en) * | 1974-03-05 | 1975-10-03 | Delalande Sa | Beta-(4-amino-6-methylpyrimidin-5-yl)propionic acid derivs - with antiulcer, bronchodilator, anticholinergic, hypotensive, diuretic and vasodilator activity |
US4122259A (en) * | 1974-08-23 | 1978-10-24 | Glaxo Laboratories Limited | 7β-[2-Aryl-2-(etherified oximino)acetamido]-3-N-substituted carbamoyloxymethylceph-3-em-4-carboxylic acids |
JPS604171B2 (ja) * | 1974-12-05 | 1985-02-01 | 久光製薬株式会社 | 新規な2−アニリノピリジン−3−酢酸誘導体の製造法 |
DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
CA1088049A (en) * | 1975-06-03 | 1980-10-21 | Takashi Masugi | 3-substituted-7-substituted alkanamido-3-cephem-4- carboxylic acid compounds and processes for preparation thereof |
US4152433A (en) * | 1976-03-12 | 1979-05-01 | Fujisawa Pharmaceutical Co., Ltd. | 2-Lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds and pharmaceutical compositions |
US4166115A (en) * | 1976-04-12 | 1979-08-28 | Fujisawa Pharmaceutical Co., Ltd. | Syn 7-oxoimino substituted derivatives of cephalosporanic acid |
US4104469A (en) * | 1977-04-15 | 1978-08-01 | Bristol-Myers Company | 7-(Syn-α-alkoxy-iminofuryl)acetamido-3-(2-methyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids |
NL7714319A (nl) * | 1976-12-27 | 1978-06-29 | Fujisawa Pharmaceutical Co | Cefalosporineverbindingen en werkwijzen om deze te bereiden. |
IT1192287B (it) * | 1977-11-14 | 1988-03-31 | Fujisawa Pharmaceutical Co | Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione |
-
1978
- 1978-11-09 IT IT29653/78A patent/IT1192287B/it active
- 1978-11-10 GB GB7843984A patent/GB2010840B/en not_active Expired
- 1978-11-10 AT AT0807178A patent/AT369005B/de not_active IP Right Cessation
- 1978-11-10 FR FR7831898A patent/FR2411839B1/fr not_active Expired
- 1978-11-10 DK DK502078A patent/DK502078A/da not_active Application Discontinuation
- 1978-11-10 DE DE19782848912 patent/DE2848912A1/de active Granted
- 1978-11-10 CA CA000316120A patent/CA1120923A/en not_active Expired
- 1978-11-10 SE SE7811637A patent/SE7811637L/xx unknown
- 1978-11-13 AU AU41546/78A patent/AU523346B2/en not_active Expired
- 1978-11-13 CH CH1166778A patent/CH645904A5/de not_active IP Right Cessation
- 1978-11-13 HU HU78FU368A patent/HU183008B/hu unknown
- 1978-11-13 NL NL7811220A patent/NL7811220A/xx not_active Application Discontinuation
- 1978-11-13 HU HU80281A patent/HU182098B/hu unknown
- 1978-11-13 ES ES475035A patent/ES475035A1/es not_active Expired
- 1978-11-14 JP JP14028678A patent/JPS5492987A/ja active Granted
-
1979
- 1979-03-26 FR FR7907572A patent/FR2413369A1/fr active Granted
- 1979-04-24 US US06/032,778 patent/US4267176A/en not_active Expired - Lifetime
- 1979-10-16 ES ES485066A patent/ES485066A1/es not_active Expired
- 1979-10-16 ES ES485068A patent/ES485068A1/es not_active Expired
- 1979-10-16 ES ES485065A patent/ES485065A1/es not_active Expired
- 1979-10-16 ES ES485067A patent/ES485067A1/es not_active Expired
-
1980
- 1980-12-05 US US06/213,684 patent/US4395411A/en not_active Expired - Lifetime
-
1984
- 1984-01-23 SE SE8400332A patent/SE8400332L/xx not_active Application Discontinuation
-
1985
- 1985-09-19 US US06/777,867 patent/US4596869A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4596869A (en) | 1986-06-24 |
DE2848912A1 (de) | 1979-05-17 |
AT369005B (de) | 1982-11-25 |
AU4154678A (en) | 1979-05-24 |
HU182098B (en) | 1983-12-28 |
US4267176A (en) | 1981-05-12 |
CH645904A5 (de) | 1984-10-31 |
ES485067A1 (es) | 1980-06-16 |
HU183008B (en) | 1984-04-28 |
IT1192287B (it) | 1988-03-31 |
DE2848912C2 (de) | 1990-10-04 |
FR2413369A1 (fr) | 1979-07-27 |
SE8400332D0 (sv) | 1984-01-23 |
ES485066A1 (es) | 1980-06-16 |
SE8400332L (sv) | 1984-01-23 |
ES485065A1 (es) | 1980-06-16 |
FR2411839B1 (fr) | 1985-09-27 |
GB2010840A (en) | 1979-07-04 |
JPS6320832B2 (de) | 1988-04-30 |
SE7811637L (sv) | 1979-05-15 |
JPS5492987A (en) | 1979-07-23 |
US4395411A (en) | 1983-07-26 |
CA1120923A (en) | 1982-03-30 |
AU523346B2 (en) | 1982-07-22 |
DK502078A (da) | 1979-05-15 |
IT7829653A0 (it) | 1978-11-09 |
FR2413369B1 (de) | 1984-04-06 |
ES475035A1 (es) | 1980-01-01 |
FR2411839A1 (fr) | 1979-07-13 |
ES485068A1 (es) | 1980-06-16 |
GB2010840B (en) | 1982-12-22 |
NL7811220A (nl) | 1979-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT358557B (de) | Verfahren zur herstellung von neuen substi- tuierten 3-phenoxy-phenylthioalkancarbonsaeure- derivaten | |
AT368168B (de) | Verfahren zur herstellung von neuen thioetiansaeurederivaten | |
ATA807178A (de) | Verfahren zur herstellung von neuen cephalosporan-saeurederivaten | |
AT367430B (de) | Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten | |
ATA283676A (de) | Verfahren zur herstellung von neuen phenylalkancarbonsaure-derivaten | |
AT343810B (de) | Verfahren zur herstellung von neuen fusidinsaurederivaten | |
ATA292078A (de) | Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten | |
AT351675B (de) | Verfahren zur herstellung von neuen clavulan- saeurethioaethern | |
AT357693B (de) | Verfahren zur herstellung von neuen ergolen- -derivaten | |
AT379382B (de) | Verfahren zur herstellung von neuen n-substituierten aziridin-2-carbonsaeurederivaten | |
AT358577B (de) | Verfahren zur herstellung von neuen 1-acyl-4- -hydroxy-imidazol-5-carboxamid-derivaten | |
AT365564B (de) | Verfahren zur herstellung von neuen alpha-phenylbenzylidenaminoalkansaeurederivaten | |
ATA72977A (de) | Verfahren zur herstellung von neuen derivaten der 3-carbamoyloxy-methyl-7-(amino-4- thiazolyl-acetamido)-cepahlosporansaeure | |
AT347963B (de) | Verfahren zur herstellung von neuen 4- halogenazetidinon-1-essigsaeurederivaten | |
AT370106B (de) | Verfahren zur herstellung von neuen penicillansaeurederivaten | |
AT365170B (de) | Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten | |
AT363462B (de) | Verfahren zur herstellung von neuen arylalkansaeurederivaten | |
AT358748B (de) | Verfahren zur herstellung von neuen d-homo- steroiden | |
ATA897178A (de) | Verfahren zur herstellung von 2-acetamidozimt- saeuren | |
AT364847B (de) | Verfahren zur herstellung von neuen clavulansaeurederivaten | |
ATA311378A (de) | Verfahren zur herstellung von neuen halogen- arylmalonamidooxacephalosporinen | |
ATA259780A (de) | Verfahren zur herstellung von neuen 6-betasubstituierten penicillansaeurederivaten | |
AT358189B (de) | Verfahren zur herstellung von neuen aspidosper- midinen | |
AT356301B (de) | Verfahren zur herstellung von neuen d-homo- steroiden | |
ATA564779A (de) | Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |